Skip to main content

Full Schedule

Full Schedule

  • Wednesday, September 20, 2023
  • 8:00 AM – 9:00 AM .
    Better Care for Psoriasis Patients
  • 9:15 AM – 10:15 AM .
    Neutrophilic dermatoses; Challenging clinico-pathologic cases
  • 10:30 AM – 11:15 AM .
    Understanding TYK2 as a Therapeutic Target in the Management of Moderate to Severe Psoriasis
  • 11:30 AM – 12:45 PM .
    The Clinical Potential of Interleukin Inhibitors in the Treatment of Psoriasis and Psoriatic Arthritis
  • 12:45 PM – 1:15 PM .
    Break
  • 1:15 PM – 2:15 PM .
    Innovation Theater (non-accredited)
  • 2:30 PM – 3:15 PM .
    The Evolving Role of Topical PDE-4 Inhibitors for the Management of Immune-Mediated Inflammatory Skin Conditions
  • 3:30 PM – 4:30 PM .
    Innovation Theater (non-accredited)
  • 4:45 PM – 5:30 PM .
    Skin Complications of Gastrointestinal Diseases